v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 89,503 $ 72,211
Accounts receivable, net 320,462 286,314
Inventory, net 159,104 132,341
Other current assets and prepaid expenses 29,980 32,313
Total current assets 599,049 523,179
Property, plant and equipment, net 139,069 140,554
Intangible assets, net 456,309 475,002
In-process research and development 590,200 590,200
Goodwill 676,162 680,602
Investments 10,410 15,731
Operating lease right-of-use assets 38,631 37,735
Other assets 9,745 10,060
Total assets 2,519,575 2,473,063
Current liabilities:    
Accounts payable 162,690 100,883
Accrued expenses 213,119 240,869
Current maturities of operating leases 10,305 9,028
Current portion of lines of credit and notes payable 17,816 24,703
Total current liabilities 403,930 375,483
Operating lease liabilities 32,394 29,760
Convertible notes 224,782 221,989
Deferred tax liabilities 135,244 137,208
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 26,711 37,072
Total long-term liabilities 419,131 426,029
Total liabilities 823,061 801,512
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 670,703,076 and 670,585,576 shares issued at March 31, 2021 and December 31, 2020, respectively 6,707 6,706
Treasury Stock - 549,907 shares at March 31, 2021 and December 31, 2020, respectively (1,791) (1,791)
Additional paid-in capital 3,155,648 3,152,694
Accumulated other comprehensive loss (13,295) (4,225)
Accumulated deficit (1,450,755) (1,481,833)
Total shareholders’ equity 1,696,514 1,671,551
Total liabilities and equity $ 2,519,575 $ 2,473,063

Source